CHCT CEO receives 29,941 restricted shares at $16.70

Community Healthcare Trust Inc. CEO and President David H. Dupuy reported an equity compensation grant of 29,941 shares of common stock on January 15, 2026.

Rhea-AI Filing Summary

Community Healthcare Trust Inc. CEO and President David H. Dupuy reported an equity compensation grant of 29,941 shares of common stock on January 15, 2026. The shares were acquired at a price of $16.70 per share and increased his beneficial ownership to 534,245 common shares, held directly.

For 2026, Mr. Dupuy agreed to take 50% of his salary in restricted stock with a five-year restriction period. Because he elected this structure, the company awarded him additional restricted stock equal to 25% of his annual salary. The acquisition price was based on the average trading price of the company’s common stock over the 10 trading days immediately preceding January 15, 2026.

Insider Trade Summary

Grant/Award: 29,941 shares

Grant/Award 1 txn

Insider Dupuy David H.

Role CEO and President

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	29,941	$16.70	$500K

Holdings After Transaction: Common Stock — 534,245 shares (Direct)

Footnotes (1)

1. F1. For 2026, the reporting person agreed to take 50% of his salary in shares of restricted stock with a five-year restriction period. Because the reporting person elected to take 50% of his base salary for 2026 in shares of restricted stock with a five-year restriction period, the Company awarded Mr. Dupuy additional compensation, in restricted stock, equal to 25% of his annual salary. The price of the securities acquired by the reporting person is based on the average price of the Company's common stock for the 10 trading days immediately preceding January 15, 2026, which was $16.70.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did CHCT CEO David Dupuy report on January 15, 2026?

CHCT CEO and President David H. Dupuy reported acquiring 29,941 shares of Community Healthcare Trust Inc. common stock on January 15, 2026, coded as an acquisition of non-derivative securities.

How many Community Healthcare Trust (CHCT) shares does the CEO own after this Form 4 transaction?

Following the reported transaction, CEO David H. Dupuy beneficially owned 534,245 shares of Community Healthcare Trust Inc. common stock, held directly.

What was the price used for the restricted stock granted to CHCT’s CEO?

The restricted stock granted to the CEO was valued at $16.70 per share, based on the average price of CHCT common stock over the 10 trading days immediately preceding January 15, 2026.

How is CHCT CEO David Dupuy’s 2026 salary structured according to this Form 4?

For 2026, the CEO agreed to take 50% of his salary in shares of restricted stock with a five-year restriction period. Because he chose this structure, the company also awarded him additional restricted stock equal to 25% of his annual salary.

Are the shares reported in this CHCT Form 4 directly owned by the CEO?

Yes. The Form 4 indicates that the 534,245 shares of Community Healthcare Trust Inc. common stock are held with direct ownership by CEO David H. Dupuy, with no indirect ownership entity noted.

What type of security is reported in this Community Healthcare Trust (CHCT) Form 4 filing?

The filing reports a transaction in non-derivative securities, specifically Community Healthcare Trust Inc. common stock. No derivative securities are listed in Table II.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 01/20/2026 - 04:21 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Dupuy David H.

(Last) (First) (Middle)

3326 ASPEN GROVE DR

SUITE 150

(Street)

FRANKLIN TN 37067

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Community Healthcare Trust Inc [ CHCT ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	CEO and President

3. Date of Earliest Transaction (Month/Day/Year)
01/15/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	01/15/2026		A		29,941(1)	A	$16.7	534,245	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. For 2026, the reporting person agreed to take 50% of his salary in shares of restricted stock with a five-year restriction period. Because the reporting person elected to take 50% of his base salary for 2026 in shares of restricted stock with a five-year restriction period, the Company awarded Mr. Dupuy additional compensation, in restricted stock, equal to 25% of his annual salary. The price of the securities acquired by the reporting person is based on the average price of the Company's common stock for the 10 trading days immediately preceding January 15, 2026, which was $16.70.

Remarks:

	/s/ Nathanael P. Kibler, Attorney-in-fact	01/20/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.